| | | | | | | | | | |
|
|
| Dockets Entered
On June 20, 2005
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1995P-0099
|
| Permit term Polyols in Lieu of Sugar Alcohols on Food Label
|
|
|
| 1998V-1269
|
| Laser Light Show
|
|
|
| 2003N-0528
|
| Revision of the Requirements for Spore-Forming Microorganisms
|
|
|
| 2004N-0456
|
| Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
|
|
|
|
|
|
| 2005N-0147
|
| Sprout Safety Public Meeting
|
|
|
| 2005P-0244
|
| Determine that it is suitable to submit an ANDA for a product strenght ( dexamethasone USP, 1.5 mg tablets ) whose innovator and manufacturer ( Merck ) has discontinued the manufacture of this tablet
|
|
|
|
|
|
|
| 1995P-0099
|
| Permit term Polyols in Lieu of Sugar Alcohols on Food Label
|
|
|
| SUP
1
|
| Calorie Control Council
|
| Vol #:
|
| 1
|
|
|
| 1998V-1269
|
| Laser Light Show
|
|
|
| EXP 1
|
| Wild Adventures Valdosta LLC
|
| Vol #:
|
| 1
|
|
|
| 2003N-0528
|
| Revision of the Requirements for Spore-Forming Microorganisms
|
|
|
| C
3
|
| Novozymes
|
| Vol #:
|
| 1
|
|
|
| EMC
1
|
| Merck Research Laboratories
|
| Vol #:
|
| 1
|
|
|
| 2004N-0456
|
| Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
|
|
|
|
|
|
| C
58
|
| Snack Food Association
|
| Vol #:
|
| 5
|
|
|
| EMC 750
|
| M. Grim
|
| Vol #:
|
| 4
|
|
|
| EMC 751
|
| K. Weiszmann Fox
|
| Vol #:
|
| 4
|
|
|
| EMC 752
|
| S. Brown
|
| Vol #:
|
| 4
|
|
|
| EMC 753
|
| J. Stover
|
| Vol #:
|
| 4
|
|
|
| EMC 754
|
| A. De' Martino
|
| Vol #:
|
| 4
|
|
|
| EMC 755
|
| B. Hahn
|
| Vol #:
|
| 4
|
|
|
| EMC 756
|
| J. Pedersen
|
| Vol #:
|
| 4
|
|
|
| EMC 757
|
| J. Ostrem
|
| Vol #:
|
| 4
|
|
|
| EMC 758
|
| K. Salas
|
| Vol #:
|
| 4
|
|
|
| 2005N-0147
|
| Sprout Safety Public Meeting
|
|
|
| C
1
|
| Louie Foods International
|
| Vol #:
|
| 1
|
|
|
| 2005P-0244
|
| Determine that it is suitable to submit an ANDA for a product strenght ( dexamethasone USP, 1.5 mg tablets ) whose innovator and manufacturer ( Merck ) has discontinued the manufacture of this tablet
|
|
|
|
|
|
|
| ACK
1
|
| ECR Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
| CP
1
|
| ECR Pharmaceuticals
|
| Vol #:
|
| 1
|
|